DISCONTINUATION OF IMMUNOSUPPRESSIVES IN PATIENTS WITH CROHN´S DISEASE TREATED WITH SCHEDULED MAINTENANCE INFLIXIMAB: PROSPECTIVE LONG TERM FOLLOW-UP AND INFLUENCE ON INFLIXIMAB TROUGH LEVELS

(1) Imelda Gi Clinical, Research Center, Gastroenterology, Bonheiden, Belgium

(2) gastroenterology, UniversityHospitals Leuven, Leuven, Belgium

(3) Immunopharmacogenetics oftherapeutics, UniversitéFrançois Rabelais, Tours, France



This item was part of the Anti-TNF in IBD: Mono versus combo - safety matters session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A80